Molecular Studies of Hematological Malignancies: Emphasis on Development of Flow-Cytometry and Cell-Sorting-Based Technics for Improving Diagnosis
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 24 May 2024 | Viewed by 1214
Special Issue Editors
2. Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
Interests: hematological malignancies; laboratory aspects of hematological malignancies, soluable and flow-cytometry based biomarkers for diagnosis, classification, prognosis, tailored treatment, treatment respnse and treatment side effects
Special Issue Information
Dear Colleagues,
The diagnosis and classification of hematological malignancies and other blood-related disorders are critical for disease treatment. Improving the diagnostic work of the hematology laboratory is also the main target of many researchers. The development of flow cytometry and cell sorting-based techniques could play an important role in the improvement of diagnosis of blood cancers in general, and in minimally invasive tissue biopsies in particular. Understanding the diagnostic potential of soluble blood levels of the Brain-Derived Neurotrophic Factor (BDNF) in hematological diseases may also bring great inspiration for scientists.
In this Special Issue, we would like to call upon researchers, laboratory scientists, clinicians, and co-workers in the field of Hematology to share their knowledge and experience in new developments and applications using molecular techniques, such as cell-sorting techniques and flow cytometry, in hematological malignancies and other hematological diseases. In addition, submissions on the use of soluble protein-based blood biomarkers, which have the potential to improve diagnosis, prognosis, response to treatment, and therapy-related side effects in hematological diseases are also welcomed. Of special interest are studies demonstrating immediate potential for implementation in the daily laboratory workup.
Dr. Azoulay David
Dr. Netanel A Horowitz
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- laboratory hematology
- hematological malignancies
- flow cytometry and cell sorting
- soluble biomarkers
